NORAD and familial pancreatic carcinoma: In several previously published studies, NORAD was also found to be upregulated (or overexpressed) in other human carcinomas, such as pancreatic cancer,14 breast cancer,27 or colorectal cancer.15 By combining these evidences, it seems like NORAD is very likely to be aberrantly upregulated in not one, but many types of human cancers.